Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 2,822 | 4,122 | 4,378 | 5,115 | 3,115 |
| Operating Income | -2,822 | -4,122 | -4,378 | -5,115 | -3,115 |
| Pre-tax Income | -2,822 | -4,122 | -4,378 | -5,115 | -3,115 |
| Net Income Continuous | -2,822 | -4,122 | -4,378 | -5,115 | -3,115 |
| Net Income | $-2,822 | $-4,122 | $-4,378 | $-5,115 | $-3,115 |
| EPS Basic Total Ops | -0.17 | -0.26 | -0.28 | -0.38 | -0.24 |
| EPS Basic Continuous Ops | -0.17 | -0.26 | -0.28 | -0.38 | -0.24 |
| EPS Diluted Total Ops | -0.17 | -0.26 | -0.28 | -0.38 | -0.24 |
| EPS Diluted Continuous Ops | -0.17 | -0.26 | -0.28 | -0.38 | -0.24 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.26 | -0.28 | -0.38 | -0.24 |
| EBITDA(a) | $-2,822 | $-4,122 | $-4,378 | $-5,115 | $-3,115 |